Amy Schulman was Appointed as President and Chief Executive Officer at Lyndra

Date of management change: January 15, 2015 

What Happened?

Watertown, MA-based Lyndra Appointed Amy Schulman as President and Chief Executive Officer

 

About the Company

Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily. The Company`s breakthrough Extended-Release Oral Capsule is designed to provide consistent drug levels for an entire week or as long as a month, from one, normal-sized capsule – something no oral therapy has ever achieved before. Lyndra`s robust pipeline is made up of therapies with established and well-known safety profiles across a number of disease areas in which non-adherence is known to be a significant driver of outcomes, including schizophrenia and other central nervous system diseases, diabetes, cardiovascular disease and opioid abuse disorder, among others. The Company is also committed to advancing its platform across new chemical entities and a variety of critical global and public health opportunities alongside partners such as the Bill & Melinda Gates Foundation and the NIH.

 

About the Person

Amy Schulman is President and Chief Executive Officer at Lyndra. Previously, Amy held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Mir Mahj, Verzal Jen, Adams Jennifer, McManaman Cathy, Blatti Rhonda, Barry Jim, Powers Natalie, Schmidtlein Joseph, Olsen Morgan, Ellsworth Diane, Bennett Kelli

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.